Search Results - Adel Alothman

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised contro... by Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar

    Published in Trials (2020-10-01)
    Get full text
    Article


  2. 2

    Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19 by Majed Al-Jeraisy, Ahmed Alaskar, Majid Alshamrani, Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar Alqahtani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohammed Asiri, Sameera AlJohani

    Published in BMJ Open (2021-04-01)
    Get full text
    Article


  3. 3

    Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial by Mohammad Bosaeed, MD, Hanan H Balkhy, ProfMD, Sultan Almaziad, MD, Haya A Aljami, BSc, Hind Alhatmi, MD, Hala Alanazi, BSN, Mashael Alahmadi, BSc, Ayah Jawhary, MD, Mohammed W Alenazi, BSc, Abdulrahman Almasoud, BSc, Rawan Alanazi, PharmD, Mustapha Bittaye, PhD, Jeremy Aboagye, MSc, Nahla Albaalharith, BSN, Sarah Batawi, MD, Pedro Folegatti, MSc, Fernando Ramos Lopez, MSc, Katie Ewer, PhD, Khalid Almoaikel, PhD, Majed Aljeraisy, PharmD, Adel Alothman, MD, Sarah C Gilbert, ProfPhD, Naif Khalaf Alharbi, PhD

    Published in The Lancet Microbe (2022-01-01)
    Get full text
    Article


Search Tools: